A phase 3 trial shows a personalized mRNA vaccine cut melanoma recurrence or death risk by 42% when added to pembrolizumab.
Posts tagged as “oncology”
A new study shows colorectal cancer rates have surged among people under 21, with aggressive disease and common symptoms often missed, underscoring the need for earlier diagnosis.
Revolution Medicines' oral tablet Rasonque received FDA clearance, showing a 60% mortality reduction but carrying a list price of roughly $477,000 per year.